Amyloid goiter: Report of the clinical, histological and biochemical features of five cases

References

• Levin M, Franklin E C, Frangione B, Pras M. The amino acid sequence of a major non immunogiobulin component of some amyloid fibrils. J Clin Invest 1972; 51: 2773–2776
   PubMed Web of Science ®Google Scholar
• Rosenthal C I, Franklin E C, Frangione B, Greenspan J. Isolation and partial characterization of SAA - An amyloid related protein from human serum. J Immunol 1976; 116: 1415–1418
   PubMedGoogle Scholar
• Looi L M. Histomorphological variation in systemic AA amyloidosis: clues of AA protein polymorphism. Histopathology 1989; 14: 111–120
   Google Scholar
• Beckman O. Ein fall von amyloider degeneration. Virchws Arch Path Anat 1858; 13: 94–98
   Google Scholar
• Von Eiselberg F L. Uber einen fall von amyloidkropf. Arch Klin Chir 1904; 73: 649–655
   Google Scholar
• Amado J A, Onidiviela R, Palacios S, Casanova D, Manzanos J, Freijanes J. Fast growing goiter as the first clinical manifestation of systemic amyloidosis. Postgrad Med J 1982; 58: 171–172
   Google Scholar
• Kanoh T, Shimada H, Uchino H, Matsumura K. Amyloid goiter with hypothyroidism. Arch Pathol Lab Med 1989; 113: 542–544
   PubMed Web of Science ®Google Scholar
• Mache C J, Riccabona Schwingshandl M, Ranner G, Ring E, Fock C, Ratschek M, Malle E, Borkenstein M H. Ultrasound and MRI findings in a case of childhood amyloid goiter. Pediatr-Radiol 1993; 23: 565–566
   Google Scholar
• Lee V W, Rubinow A, Pehrson J, Skinner M, Cohen A S. Amyloid goiter: Preoperative scintigraphic diagnosis using Tc-99m pyrophosphate. J Nucl Med 1984; 25: 468–471
   Google Scholar
• Gertz M A, Kyle R A. Secondary systemic amyloidosis: Response and survival in 64 patients. Medicine-Baltimore 1991; 70: 246–56
   PubMed Web of Science ®Google Scholar
• Prelli F, Pras M, Frangione B. Degradation and deposition of amyloid AA fibrils are tissue specific. Biochemistry 1987; 26: 8251–8256
   PubMed Web of Science ®Google Scholar
• Talmi Y, Gal R, Finkelstein Y, Halpern M, Gafter U, Zohar Y. Amyloid goiter. J Otolaryngol 1989; 18: 251–253
   Google Scholar
• Prophet E B. Laboratory methods in histopathology. Am Registry of Pathology. 1992; 168
   Google Scholar
• Wright J R, Calkins E, Humphrey R L. Potassium permanganate reaction in amyloidosis. Lab Invest 1977; 36: 274–281
   PubMed Web of Science ®Google Scholar
• Hsu S N, Raine I, Fanger H. Use of avidinbiotin peroxidase complex (ABC) in immunoperoxidase technique. J Histochem Cytochem 1981; 29: 577–580
   PubMed Web of Science ®Google Scholar
• Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin E C. The characterization of soluble amyloid prepared in water. J Clin Invest 1968; 47: 924–933
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of a structural protein during the assembly of the head of bacteriophage Tu. Nature (LONDON) 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Glenner G G, Terry W, Harada M, Isersky C, Page D. Amyloid proteins: Proof of homolgy with immunoglobulin light chains by sequence analysis. Science 1971; 172: 1150–1151
   PubMed Web of Science ®Google Scholar
• Prelli F, Pras M, Frangione B. The primary structure of human tissue amyloid P component from a patient with primary idiopathic amyloidosis. J Biol Chem 1985; 260: 12895–12898
   Google Scholar
• Toubin H, Stachelin T, Gordon J. Proc Natl Acad Sa USA 1970; 76: 4350–4354
   Google Scholar
• Kaplan B, German G, Pras M. Characterization of amyloid proteins using milligram amount of amyloid containing tissue. J Liquid Chromatogr 1993; 16: 2249–2268
   Web of Science ®Google Scholar
• Walker G A. Amyloid goiter. Surg Gynecol Obstet 1942; 75: 374–377
   Google Scholar
• Danovitch G M, Le Roith D, Sikuler S E, Straus R. Amyloid goiter in Familial Mediterranean Fever. Clin Endocrinol Oxf 1979; 11: 595–601
   Google Scholar
• Gharib H, Goellner J R. Diagnosis of amyloidosis by fine needle aspiration biopsy of the thyroid. N Eng J Med 1981; 305: 586, Sept
   PubMed Web of Science ®Google Scholar
• Miake H, Maeda H, Isomoto I, Nagatomo H, Nakashima A, Ashozawa A. Computed tomography in amyloid goiter. J Comp Assisted Tomography 1988; 12: 621–622
   Google Scholar
• Arean V M, Klein R E. Amyloid goiter, review of the literature and report of a case. Am J Clin Pathol 1961; 36: 341–355
   PubMed Web of Science ®Google Scholar
• Kneebone R L, Greeff H, Mannell A. Amyloid goiter. A case report. S Afr Med J 1984; 65: 931–932
   PubMed Web of Science ®Google Scholar
• Kennedy J S, Thomson J A, Buchanan W M. Amyloid in the thyroid. Q J Med 1974; 43: 127–143
   Google Scholar
• Fuller R H. Hamartomatous adiposity with superimposed amyloidosis of the thyroid gland. Am J Clin Pathol 1950; 2: 188–189
   Google Scholar
• Komorowski R A, Hanson G A. Occult thyroid pathology in the young adult: An autopsy study of 138 patients without clinical thyroid disease. Hum Pathol 1988; 19: 689–696
   Google Scholar
• DeRienzo D, Truong L. Thyroid neoplasms containing mature fat: a report of two cases and review of the literature. Mod Pathol 1989; 2: 506–510
   PubMedGoogle Scholar
• Gnepp D R, Ogorzalek J M, Heffess C S. Fat containing lesions of the thyroid gland. Am J Surg Pathol 1989; 13: 605–612
   Google Scholar
• Chevsky V E, Dreese W C, Hellwig C A. Adenolipomatosis of the thyroid, a new type of goiter. Surgery 1953; 34: 38–45
   Google Scholar
• Hjorth L, Thomsen L B, Nielsen V T. Adenolipoma of the thyroid g 1 and. Histopathology 1986; 10: 91–96
   PubMedGoogle Scholar
• Husby G, Sletten K. Chemical and clinical classification of amyloidosis 1985. Scand J Immunol 1986; 23: 253–265
   PubMed Web of Science ®Google Scholar
• Moyner K, Sletten K, Husby G, Natvig J B. An unusual large amyloid fibril protein AA from a patient with Waldenstrom's macroglobulinemia and amyloidosis. Scand J Immunol 1950; 11: 549–554
   Google Scholar
• Sletten K, Husby G, Natvig J B. The complete amino acid sequence of an amyloid fibril protein AA of unusual size (64 residues). Biochem Biophys Res Commun 1976; 69: 19–25
   PubMed Web of Science ®Google Scholar
• Ein D, Kimura S, Terey W D, Magnotta J, Glenner G G. Amino acid sequence of an amyloid fibril protein of unknown origin. J Biol Chem 1972; 247: 5653–5655
   PubMed Web of Science ®Google Scholar
• Westermark G T, Sletten K, Westermark P. Massive vascular AA-amyloidosis: A histologically and biochemically distinctive subtype of reactive systemic amyloidosis. Scand J Immunol 1989; 30: 605–613
   PubMed Web of Science ®Google Scholar
• Skogen B, Sletten K, Lea T, Natvig J B. Heterogeneity of human amyloid protein AA and its related serum protein SAA. Scand J Immunol 1983; 17: 83–88
   Google Scholar
• Westermark G T, Westermark P, Sletten K. Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoid arthritis. Lab Invest 1987; 57: 57–64
   PubMedGoogle Scholar
• Baba S, Takahashi T, Kasama T, Shirasawa H. Identification of two novel amyloid protein subsets coexisting in an individual patient of AA-Amyloid. Biochim Biophys Acta 1992; 1180: 195–200
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Narindrasorasak S, Tape C, Tan R, Boudreau L. During AA amyloidogenesis is proteolytic attack on serum amyloid A a pre- or postfibrillogenic event?. Amyloid: Int J Exp Clin Invest 1994; 1: 174–183
   Web of Science ®Google Scholar
• Arai K, Miura K, Baba S, Shirasawa H. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: In vivo observations in murine spleem using anti-SAA and anti-AA. 1994; 173: 127–134
   Google Scholar
• Yakar S, Kaplan B, Livneh A, Martin B, Miura K, Ali Khan Z, Shtrasburg S, Pras M. Direct evidence for SAA deposition in tissue during murine amyloidogenesis. Scand J Immunol 1994; 40: 653–658
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Erikson M. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis. Lab Invest 1979; 41: 427–431
   Google Scholar